Reprieve Cardiovascular Raises $61M to Fund Pivotal Heart Failure Trial
What You Should Know:
– Reprieve Cardiovascular, a clinical-stage company secures $61M in Series B funding led by Deerfield Management and included participation from several other investors, such as Arboretum Ventures, Lightstone Ventures, and an…
Continue Reading
